Project
avrg: Illumina Body Map 2 (GSE30611)
Navigation
Downloads
Results for NFKB2
Z-value: 2.09
Motif logo
Transcription factors associated with NFKB2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
NFKB2
|
ENSG00000077150.20 | NFKB2 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| NFKB2 | hg38_v1_chr10_+_102394488_102394540 | 0.58 | 4.9e-04 | Click! |
Activity profile of NFKB2 motif
Sorted Z-values of NFKB2 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of NFKB2
| Promoter | Score | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr17_-_35880350 | 7.99 |
ENST00000605140.6
ENST00000651122.1 ENST00000603197.6 |
CCL5
|
C-C motif chemokine ligand 5 |
| chr19_+_41877267 | 5.97 |
ENST00000221972.8
ENST00000597454.1 ENST00000444740.2 |
CD79A
|
CD79a molecule |
| chr15_-_88895511 | 5.74 |
ENST00000562281.1
ENST00000359595.8 ENST00000562889.5 |
HAPLN3
|
hyaluronan and proteoglycan link protein 3 |
| chr20_+_45174894 | 5.72 |
ENST00000243924.4
|
PI3
|
peptidase inhibitor 3 |
| chr3_+_53161241 | 5.54 |
ENST00000477794.2
ENST00000650739.1 |
PRKCD
|
protein kinase C delta |
| chr1_-_27635176 | 5.33 |
ENST00000374005.8
|
FGR
|
FGR proto-oncogene, Src family tyrosine kinase |
| chr22_-_37244237 | 5.17 |
ENST00000401529.3
ENST00000249071.11 |
RAC2
|
Rac family small GTPase 2 |
| chr2_-_89010515 | 4.75 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
| chr2_-_89320146 | 4.71 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 |
| chr2_-_88947820 | 4.69 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
| chr2_-_89117844 | 3.99 |
ENST00000490686.1
|
IGKV1-17
|
immunoglobulin kappa variable 1-17 |
| chr22_+_38957522 | 3.97 |
ENST00000618553.1
ENST00000249116.7 |
APOBEC3A
|
apolipoprotein B mRNA editing enzyme catalytic subunit 3A |
| chr22_-_37244417 | 3.78 |
ENST00000405484.5
ENST00000441619.5 ENST00000406508.5 |
RAC2
|
Rac family small GTPase 2 |
| chr1_-_202161575 | 3.77 |
ENST00000309017.7
ENST00000477554.5 ENST00000492451.1 |
PTPN7
|
protein tyrosine phosphatase non-receptor type 7 |
| chr2_+_89913982 | 3.49 |
ENST00000390265.2
|
IGKV1D-33
|
immunoglobulin kappa variable 1D-33 |
| chr3_+_53161120 | 3.40 |
ENST00000394729.6
ENST00000330452.8 ENST00000652449.1 |
PRKCD
|
protein kinase C delta |
| chr6_+_32637396 | 3.37 |
ENST00000395363.5
ENST00000496318.5 ENST00000343139.11 |
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1 |
| chr19_+_35449584 | 3.30 |
ENST00000246549.2
|
FFAR2
|
free fatty acid receptor 2 |
| chr19_+_859654 | 3.30 |
ENST00000592860.2
ENST00000327726.11 |
CFD
|
complement factor D |
| chr19_+_48321454 | 3.30 |
ENST00000599704.5
|
EMP3
|
epithelial membrane protein 3 |
| chr2_-_89040745 | 3.28 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
| chr6_+_29942523 | 3.14 |
ENST00000376809.10
ENST00000376802.2 ENST00000638375.1 |
HLA-A
|
major histocompatibility complex, class I, A |
| chr6_+_32637419 | 3.13 |
ENST00000374949.2
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1 |
| chr4_-_73998669 | 3.10 |
ENST00000296027.5
|
CXCL5
|
C-X-C motif chemokine ligand 5 |
| chr14_-_95714114 | 3.04 |
ENST00000402399.6
ENST00000555202.1 |
TCL1A
|
TCL1 family AKT coactivator A |
| chr17_+_16415553 | 3.04 |
ENST00000338560.12
|
TRPV2
|
transient receptor potential cation channel subfamily V member 2 |
| chr16_+_30473946 | 3.03 |
ENST00000569725.1
|
ITGAL
|
integrin subunit alpha L |
| chr5_+_136058849 | 3.00 |
ENST00000508076.5
|
TGFBI
|
transforming growth factor beta induced |
| chrX_+_65667645 | 2.96 |
ENST00000360270.7
|
MSN
|
moesin |
| chr19_-_41353904 | 2.96 |
ENST00000221930.6
|
TGFB1
|
transforming growth factor beta 1 |
| chr1_-_206923183 | 2.95 |
ENST00000525793.5
|
FCMR
|
Fc fragment of IgM receptor |
| chr2_-_196171565 | 2.92 |
ENST00000263955.9
|
STK17B
|
serine/threonine kinase 17b |
| chr1_-_151993822 | 2.89 |
ENST00000368811.8
|
S100A10
|
S100 calcium binding protein A10 |
| chr1_-_84997079 | 2.85 |
ENST00000284027.5
ENST00000370608.8 |
MCOLN2
|
mucolipin TRP cation channel 2 |
| chr2_-_89100352 | 2.85 |
ENST00000479981.1
|
IGKV1-16
|
immunoglobulin kappa variable 1-16 |
| chr17_+_74466627 | 2.80 |
ENST00000360141.8
ENST00000392625.7 ENST00000310828.9 ENST00000361933.7 |
CD300A
|
CD300a molecule |
| chr1_-_206923242 | 2.78 |
ENST00000529560.1
|
FCMR
|
Fc fragment of IgM receptor |
| chr19_+_17527250 | 2.78 |
ENST00000599164.6
ENST00000449408.6 ENST00000600871.5 ENST00000599124.1 |
NIBAN3
|
niban apoptosis regulator 3 |
| chr1_-_183590876 | 2.72 |
ENST00000367536.5
|
NCF2
|
neutrophil cytosolic factor 2 |
| chr7_+_142715314 | 2.70 |
ENST00000390399.3
|
TRBV27
|
T cell receptor beta variable 27 |
| chr14_+_51847145 | 2.66 |
ENST00000615906.4
|
GNG2
|
G protein subunit gamma 2 |
| chr17_+_74466386 | 2.65 |
ENST00000648095.1
|
CD300A
|
CD300a molecule |
| chr6_+_31400699 | 2.62 |
ENST00000674131.1
ENST00000673647.1 ENST00000673857.1 |
MICA
ENSG00000288587.1
|
MHC class I polypeptide-related sequence A novel transcript |
| chr12_-_52520371 | 2.61 |
ENST00000549420.1
ENST00000252242.9 ENST00000551275.1 ENST00000546577.1 |
KRT5
|
keratin 5 |
| chr7_-_38363476 | 2.60 |
ENST00000426402.2
|
TRGV2
|
T cell receptor gamma variable 2 |
| chr1_-_183590596 | 2.56 |
ENST00000418089.5
ENST00000413720.5 |
NCF2
|
neutrophil cytosolic factor 2 |
| chr6_+_106360668 | 2.53 |
ENST00000633556.3
|
CRYBG1
|
crystallin beta-gamma domain containing 1 |
| chr1_-_186680411 | 2.52 |
ENST00000367468.10
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 |
| chr2_+_90159840 | 2.52 |
ENST00000377032.5
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
| chr1_-_47190013 | 2.43 |
ENST00000294338.7
|
PDZK1IP1
|
PDZK1 interacting protein 1 |
| chr17_-_5583957 | 2.37 |
ENST00000354411.7
ENST00000577119.5 |
NLRP1
|
NLR family pyrin domain containing 1 |
| chrX_-_154366334 | 2.34 |
ENST00000673639.2
|
FLNA
|
filamin A |
| chr8_+_23084355 | 2.33 |
ENST00000397703.6
ENST00000520607.1 |
ENSG00000284948.1
ENSG00000284956.1
|
novel transcript novel protein |
| chr19_-_4540028 | 2.26 |
ENST00000306390.7
|
LRG1
|
leucine rich alpha-2-glycoprotein 1 |
| chr19_+_45001430 | 2.24 |
ENST00000625761.2
ENST00000505236.1 ENST00000221452.13 |
RELB
|
RELB proto-oncogene, NF-kB subunit |
| chr10_+_102394488 | 2.22 |
ENST00000369966.8
|
NFKB2
|
nuclear factor kappa B subunit 2 |
| chr17_-_3916455 | 2.21 |
ENST00000225538.4
|
P2RX1
|
purinergic receptor P2X 1 |
| chr19_-_3786254 | 2.19 |
ENST00000585778.5
|
MATK
|
megakaryocyte-associated tyrosine kinase |
| chr1_-_183635776 | 2.18 |
ENST00000359856.11
|
ARPC5
|
actin related protein 2/3 complex subunit 5 |
| chr7_+_2519763 | 2.18 |
ENST00000222725.10
ENST00000359574.7 |
LFNG
|
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
| chr17_+_78130759 | 2.17 |
ENST00000590426.1
ENST00000318430.10 ENST00000590799.5 ENST00000589691.1 |
TMC8
|
transmembrane channel like 8 |
| chr16_-_28181034 | 2.14 |
ENST00000570033.1
|
XPO6
|
exportin 6 |
| chr1_+_23791962 | 2.14 |
ENST00000421070.1
|
LYPLA2
|
lysophospholipase 2 |
| chrX_+_72079756 | 2.13 |
ENST00000632230.1
|
NHSL2
|
NHS like 2 |
| chr10_-_124092390 | 2.13 |
ENST00000628426.1
|
CHST15
|
carbohydrate sulfotransferase 15 |
| chr22_+_25564818 | 2.11 |
ENST00000619906.4
|
GRK3
|
G protein-coupled receptor kinase 3 |
| chr10_-_124092445 | 2.10 |
ENST00000346248.7
|
CHST15
|
carbohydrate sulfotransferase 15 |
| chr14_+_51847116 | 2.09 |
ENST00000553560.5
|
GNG2
|
G protein subunit gamma 2 |
| chr3_+_53161501 | 2.08 |
ENST00000487897.5
|
PRKCD
|
protein kinase C delta |
| chr5_+_35852695 | 2.02 |
ENST00000508941.5
|
IL7R
|
interleukin 7 receptor |
| chr22_+_36922040 | 2.01 |
ENST00000406230.5
|
CSF2RB
|
colony stimulating factor 2 receptor subunit beta |
| chr8_-_65842051 | 2.01 |
ENST00000401827.8
|
PDE7A
|
phosphodiesterase 7A |
| chr12_+_6946468 | 1.99 |
ENST00000543115.5
ENST00000399448.5 |
PTPN6
|
protein tyrosine phosphatase non-receptor type 6 |
| chr19_+_53867874 | 1.99 |
ENST00000448420.5
ENST00000439000.5 ENST00000391771.1 ENST00000391770.9 |
MYADM
|
myeloid associated differentiation marker |
| chr14_+_92323154 | 1.98 |
ENST00000532405.6
ENST00000676001.1 ENST00000531433.5 |
SLC24A4
|
solute carrier family 24 member 4 |
| chr12_+_8509460 | 1.98 |
ENST00000382064.6
|
CLEC4D
|
C-type lectin domain family 4 member D |
| chr15_+_76995118 | 1.98 |
ENST00000558012.6
ENST00000379595.7 |
PSTPIP1
|
proline-serine-threonine phosphatase interacting protein 1 |
| chr17_+_42288464 | 1.97 |
ENST00000590726.7
ENST00000678903.1 ENST00000590949.6 ENST00000676585.1 ENST00000588868.5 |
STAT5A
|
signal transducer and activator of transcription 5A |
| chr2_-_88992903 | 1.93 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
| chr14_-_22829779 | 1.89 |
ENST00000488800.5
|
SLC7A7
|
solute carrier family 7 member 7 |
| chr16_+_81444799 | 1.88 |
ENST00000537098.8
|
CMIP
|
c-Maf inducing protein |
| chr3_-_13420307 | 1.88 |
ENST00000254508.7
|
NUP210
|
nucleoporin 210 |
| chr11_+_34438900 | 1.86 |
ENST00000241052.5
|
CAT
|
catalase |
| chr8_+_22579100 | 1.84 |
ENST00000452226.5
ENST00000397760.8 |
PDLIM2
|
PDZ and LIM domain 2 |
| chr16_-_4416621 | 1.84 |
ENST00000570645.5
ENST00000574025.5 ENST00000572898.1 ENST00000537233.6 ENST00000571059.5 |
CORO7
|
coronin 7 |
| chr6_+_143678048 | 1.83 |
ENST00000542769.5
ENST00000397980.3 |
PHACTR2
|
phosphatase and actin regulator 2 |
| chrX_+_49171889 | 1.82 |
ENST00000376327.6
|
PLP2
|
proteolipid protein 2 |
| chrX_+_49171918 | 1.79 |
ENST00000376322.7
|
PLP2
|
proteolipid protein 2 |
| chr6_+_143677935 | 1.77 |
ENST00000440869.6
ENST00000367582.7 ENST00000451827.6 |
PHACTR2
|
phosphatase and actin regulator 2 |
| chr2_+_218217131 | 1.75 |
ENST00000420104.5
ENST00000315717.10 ENST00000295685.14 |
ARPC2
|
actin related protein 2/3 complex subunit 2 |
| chr16_+_31527876 | 1.74 |
ENST00000302312.9
ENST00000564707.1 |
AHSP
|
alpha hemoglobin stabilizing protein |
| chr5_+_131264043 | 1.73 |
ENST00000505065.2
ENST00000503291.5 ENST00000360515.7 |
CDC42SE2
|
CDC42 small effector 2 |
| chr19_-_47231191 | 1.72 |
ENST00000439096.3
|
BBC3
|
BCL2 binding component 3 |
| chr19_-_3786363 | 1.71 |
ENST00000310132.11
|
MATK
|
megakaryocyte-associated tyrosine kinase |
| chr15_+_91853690 | 1.70 |
ENST00000318445.11
|
SLCO3A1
|
solute carrier organic anion transporter family member 3A1 |
| chr15_-_64356074 | 1.68 |
ENST00000634811.1
ENST00000303052.13 ENST00000607537.6 |
CSNK1G1
|
casein kinase 1 gamma 1 |
| chr16_-_88811897 | 1.68 |
ENST00000569616.1
ENST00000563655.5 ENST00000567713.5 ENST00000426324.6 ENST00000378364.8 |
APRT
|
adenine phosphoribosyltransferase |
| chr2_+_218880844 | 1.67 |
ENST00000258411.8
|
WNT10A
|
Wnt family member 10A |
| chr17_+_42288429 | 1.66 |
ENST00000676631.1
ENST00000677893.1 |
STAT5A
|
signal transducer and activator of transcription 5A |
| chr16_-_381935 | 1.65 |
ENST00000431232.7
ENST00000250930.7 |
PGAP6
|
post-glycosylphosphatidylinositol attachment to proteins 6 |
| chr4_+_73869385 | 1.64 |
ENST00000395761.4
|
CXCL1
|
C-X-C motif chemokine ligand 1 |
| chr1_-_183635659 | 1.63 |
ENST00000367534.5
ENST00000294742.6 |
ARPC5
|
actin related protein 2/3 complex subunit 5 |
| chr8_-_6938301 | 1.63 |
ENST00000297435.3
|
DEFA4
|
defensin alpha 4 |
| chr3_-_39153512 | 1.61 |
ENST00000273153.10
|
CSRNP1
|
cysteine and serine rich nuclear protein 1 |
| chr1_-_155911365 | 1.61 |
ENST00000651833.1
ENST00000539040.5 ENST00000651853.1 |
RIT1
|
Ras like without CAAX 1 |
| chr7_-_5423543 | 1.60 |
ENST00000399537.8
|
TNRC18
|
trinucleotide repeat containing 18 |
| chr8_+_22579139 | 1.60 |
ENST00000397761.6
|
PDLIM2
|
PDZ and LIM domain 2 |
| chr1_+_111227699 | 1.60 |
ENST00000369748.9
|
CHI3L2
|
chitinase 3 like 2 |
| chr1_+_2555639 | 1.60 |
ENST00000426449.5
ENST00000434817.5 ENST00000435221.6 |
TNFRSF14
|
TNF receptor superfamily member 14 |
| chr2_+_201183120 | 1.59 |
ENST00000272879.9
ENST00000286186.11 ENST00000374650.7 ENST00000346817.9 ENST00000313728.11 ENST00000448480.1 |
CASP10
|
caspase 10 |
| chr9_+_131228109 | 1.58 |
ENST00000498010.2
ENST00000476004.5 ENST00000528406.1 |
NUP214
|
nucleoporin 214 |
| chr1_-_36323593 | 1.58 |
ENST00000490466.2
|
EVA1B
|
eva-1 homolog B |
| chr1_+_2555961 | 1.57 |
ENST00000451778.5
|
TNFRSF14
|
TNF receptor superfamily member 14 |
| chr1_-_202160577 | 1.56 |
ENST00000629151.2
ENST00000476061.5 ENST00000464870.5 ENST00000467283.5 ENST00000435759.6 ENST00000486116.5 ENST00000477625.5 |
PTPN7
|
protein tyrosine phosphatase non-receptor type 7 |
| chr19_+_17527232 | 1.56 |
ENST00000601861.5
|
NIBAN3
|
niban apoptosis regulator 3 |
| chr1_+_2556361 | 1.55 |
ENST00000355716.5
|
TNFRSF14
|
TNF receptor superfamily member 14 |
| chr2_-_108989206 | 1.54 |
ENST00000258443.7
ENST00000409271.5 ENST00000376651.1 |
EDAR
|
ectodysplasin A receptor |
| chr6_+_31572279 | 1.52 |
ENST00000418386.3
|
LTA
|
lymphotoxin alpha |
| chr9_+_128149447 | 1.51 |
ENST00000277480.7
ENST00000372998.1 |
LCN2
|
lipocalin 2 |
| chr15_+_84748554 | 1.51 |
ENST00000560079.7
|
ZNF592
|
zinc finger protein 592 |
| chr2_+_10043524 | 1.49 |
ENST00000305883.6
|
KLF11
|
Kruppel like factor 11 |
| chr16_+_50742110 | 1.47 |
ENST00000566679.6
ENST00000564634.5 ENST00000398568.6 |
CYLD
|
CYLD lysine 63 deubiquitinase |
| chr5_+_131264008 | 1.47 |
ENST00000395246.5
|
CDC42SE2
|
CDC42 small effector 2 |
| chr7_-_5423826 | 1.46 |
ENST00000430969.6
|
TNRC18
|
trinucleotide repeat containing 18 |
| chr1_+_111227610 | 1.46 |
ENST00000369744.6
|
CHI3L2
|
chitinase 3 like 2 |
| chr5_-_151087131 | 1.46 |
ENST00000315050.11
ENST00000523338.5 ENST00000522100.5 |
TNIP1
|
TNFAIP3 interacting protein 1 |
| chr5_-_98928992 | 1.44 |
ENST00000614616.5
|
CHD1
|
chromodomain helicase DNA binding protein 1 |
| chr16_-_88856909 | 1.44 |
ENST00000569433.1
ENST00000268695.10 ENST00000568311.1 |
GALNS
|
galactosamine (N-acetyl)-6-sulfatase |
| chr8_+_22578735 | 1.43 |
ENST00000339162.11
ENST00000308354.11 |
PDLIM2
|
PDZ and LIM domain 2 |
| chr15_+_91853819 | 1.43 |
ENST00000424469.2
|
SLCO3A1
|
solute carrier organic anion transporter family member 3A1 |
| chr12_-_54419259 | 1.41 |
ENST00000293379.9
|
ITGA5
|
integrin subunit alpha 5 |
| chr1_-_202159977 | 1.41 |
ENST00000367279.8
|
PTPN7
|
protein tyrosine phosphatase non-receptor type 7 |
| chr14_-_91867529 | 1.40 |
ENST00000435962.7
|
TC2N
|
tandem C2 domains, nuclear |
| chr16_-_74700845 | 1.39 |
ENST00000308807.12
ENST00000573267.1 |
MLKL
|
mixed lineage kinase domain like pseudokinase |
| chr22_+_35400115 | 1.39 |
ENST00000382011.9
ENST00000216122.9 ENST00000416905.1 |
MCM5
|
minichromosome maintenance complex component 5 |
| chr4_-_74038681 | 1.39 |
ENST00000296026.4
|
CXCL3
|
C-X-C motif chemokine ligand 3 |
| chr14_-_50831046 | 1.38 |
ENST00000476352.5
ENST00000324330.13 ENST00000382041.7 ENST00000453401.6 ENST00000530997.7 |
NIN
|
ninein |
| chr16_-_67247460 | 1.37 |
ENST00000258201.9
|
FHOD1
|
formin homology 2 domain containing 1 |
| chr11_+_67583742 | 1.36 |
ENST00000398603.6
|
GSTP1
|
glutathione S-transferase pi 1 |
| chr16_-_4416564 | 1.34 |
ENST00000572467.5
ENST00000251166.9 ENST00000572044.1 ENST00000571052.5 |
CORO7-PAM16
CORO7
|
CORO7-PAM16 readthrough coronin 7 |
| chr19_+_18433234 | 1.34 |
ENST00000599699.2
|
SSBP4
|
single stranded DNA binding protein 4 |
| chr11_+_72814380 | 1.34 |
ENST00000534905.5
ENST00000321297.10 ENST00000540567.1 |
ATG16L2
|
autophagy related 16 like 2 |
| chr6_+_14117764 | 1.34 |
ENST00000379153.4
|
CD83
|
CD83 molecule |
| chr6_+_18155329 | 1.33 |
ENST00000546309.6
|
KDM1B
|
lysine demethylase 1B |
| chr9_+_79572715 | 1.33 |
ENST00000265284.10
|
TLE4
|
TLE family member 4, transcriptional corepressor |
| chr19_+_3136026 | 1.33 |
ENST00000262958.4
|
GNA15
|
G protein subunit alpha 15 |
| chr20_-_4815100 | 1.33 |
ENST00000379376.2
|
RASSF2
|
Ras association domain family member 2 |
| chr1_-_204467216 | 1.33 |
ENST00000367184.2
|
PIK3C2B
|
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta |
| chr14_+_24136152 | 1.32 |
ENST00000559123.5
ENST00000206451.11 ENST00000382708.7 ENST00000561435.5 |
PSME1
|
proteasome activator subunit 1 |
| chr14_-_24146596 | 1.30 |
ENST00000560410.5
ENST00000216802.10 ENST00000615264.4 ENST00000630027.1 |
PSME2
|
proteasome activator subunit 2 |
| chr9_+_79572572 | 1.30 |
ENST00000435650.5
ENST00000414465.5 ENST00000376537.8 |
TLE4
|
TLE family member 4, transcriptional corepressor |
| chr19_-_10568968 | 1.29 |
ENST00000393599.3
|
CDKN2D
|
cyclin dependent kinase inhibitor 2D |
| chr14_-_50830641 | 1.29 |
ENST00000453196.6
ENST00000496749.1 |
NIN
|
ninein |
| chr6_-_10838503 | 1.28 |
ENST00000536370.6
ENST00000474039.5 ENST00000354489.7 ENST00000676116.1 |
MAK
|
male germ cell associated kinase |
| chr15_-_64356047 | 1.28 |
ENST00000634654.1
|
CSNK1G1
|
casein kinase 1 gamma 1 |
| chr14_-_50830479 | 1.27 |
ENST00000382043.8
|
NIN
|
ninein |
| chr17_-_18257264 | 1.26 |
ENST00000581349.5
ENST00000473425.2 |
FLII
|
FLII actin remodeling protein |
| chr6_+_18155399 | 1.26 |
ENST00000650836.2
ENST00000449850.2 ENST00000297792.9 |
KDM1B
|
lysine demethylase 1B |
| chr16_+_50742037 | 1.26 |
ENST00000569418.5
|
CYLD
|
CYLD lysine 63 deubiquitinase |
| chr17_-_55421853 | 1.24 |
ENST00000571578.1
|
MMD
|
monocyte to macrophage differentiation associated |
| chr10_-_6062290 | 1.24 |
ENST00000256876.10
ENST00000379954.5 |
IL2RA
|
interleukin 2 receptor subunit alpha |
| chr8_-_100721851 | 1.24 |
ENST00000522658.6
|
PABPC1
|
poly(A) binding protein cytoplasmic 1 |
| chr8_-_100721942 | 1.24 |
ENST00000522387.5
|
PABPC1
|
poly(A) binding protein cytoplasmic 1 |
| chr1_-_155911340 | 1.23 |
ENST00000368323.8
|
RIT1
|
Ras like without CAAX 1 |
| chr14_+_22086401 | 1.23 |
ENST00000390451.2
|
TRAV23DV6
|
T cell receptor alpha variable 23/delta variable 6 |
| chr8_-_100722036 | 1.23 |
ENST00000518196.5
ENST00000519004.5 ENST00000519363.1 ENST00000318607.10 ENST00000520142.2 |
PABPC1
|
poly(A) binding protein cytoplasmic 1 |
| chr8_-_100722174 | 1.23 |
ENST00000677380.1
ENST00000677478.1 |
PABPC1
|
poly(A) binding protein cytoplasmic 1 |
| chr5_+_177303768 | 1.23 |
ENST00000303204.9
ENST00000503216.5 |
PRELID1
|
PRELI domain containing 1 |
| chr3_+_183253795 | 1.22 |
ENST00000460419.1
|
B3GNT5
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 |
| chr22_+_25564628 | 1.21 |
ENST00000324198.11
|
GRK3
|
G protein-coupled receptor kinase 3 |
| chr1_+_26545833 | 1.21 |
ENST00000531382.5
|
RPS6KA1
|
ribosomal protein S6 kinase A1 |
| chr19_-_10569022 | 1.21 |
ENST00000335766.2
|
CDKN2D
|
cyclin dependent kinase inhibitor 2D |
| chr5_+_177304571 | 1.20 |
ENST00000503853.1
|
PRELID1
|
PRELI domain containing 1 |
| chr8_+_22589240 | 1.19 |
ENST00000450780.6
ENST00000430850.6 ENST00000447849.2 ENST00000614502.4 ENST00000443561.3 |
ENSG00000248235.6
PDLIM2
|
novel protein PDZ and LIM domain 2 |
| chr12_+_57522801 | 1.18 |
ENST00000355673.8
ENST00000546632.1 ENST00000549623.1 |
MBD6
|
methyl-CpG binding domain protein 6 |
| chr20_-_49713842 | 1.18 |
ENST00000371711.4
|
B4GALT5
|
beta-1,4-galactosyltransferase 5 |
| chr2_-_106160376 | 1.17 |
ENST00000479621.5
|
UXS1
|
UDP-glucuronate decarboxylase 1 |
| chr6_-_73523757 | 1.17 |
ENST00000455918.2
ENST00000677236.1 |
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1 |
| chr11_+_72223918 | 1.16 |
ENST00000543234.1
|
INPPL1
|
inositol polyphosphate phosphatase like 1 |
| chr8_-_102655707 | 1.16 |
ENST00000285407.11
|
KLF10
|
Kruppel like factor 10 |
| chr14_+_95686419 | 1.16 |
ENST00000340722.8
|
TCL1B
|
TCL1 family AKT coactivator B |
| chr7_-_140924699 | 1.15 |
ENST00000288602.11
ENST00000469930.2 ENST00000496384.7 |
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase |
| chr11_+_818906 | 1.15 |
ENST00000336615.9
|
PNPLA2
|
patatin like phospholipase domain containing 2 |
| chr1_+_2556222 | 1.15 |
ENST00000409119.5
|
TNFRSF14
|
TNF receptor superfamily member 14 |
| chr1_-_154970735 | 1.15 |
ENST00000368445.9
ENST00000448116.7 ENST00000368449.8 |
SHC1
|
SHC adaptor protein 1 |
| chr2_+_60881553 | 1.14 |
ENST00000394479.4
|
REL
|
REL proto-oncogene, NF-kB subunit |
| chr16_+_81779279 | 1.13 |
ENST00000564138.6
|
PLCG2
|
phospholipase C gamma 2 |
| chr17_-_55421818 | 1.12 |
ENST00000262065.8
ENST00000649377.1 |
MMD
|
monocyte to macrophage differentiation associated |
| chr11_-_96343170 | 1.12 |
ENST00000524717.6
|
MAML2
|
mastermind like transcriptional coactivator 2 |
| chr9_+_97983332 | 1.11 |
ENST00000339399.5
|
ANP32B
|
acidic nuclear phosphoprotein 32 family member B |
| chr16_+_28494634 | 1.11 |
ENST00000564831.6
ENST00000431282.2 |
APOBR
|
apolipoprotein B receptor |
| chr7_+_121062765 | 1.09 |
ENST00000423795.5
|
CPED1
|
cadherin like and PC-esterase domain containing 1 |
| chr7_+_7968787 | 1.09 |
ENST00000223145.10
|
GLCCI1
|
glucocorticoid induced 1 |
| chr13_-_110561668 | 1.08 |
ENST00000267328.5
|
RAB20
|
RAB20, member RAS oncogene family |
| chr6_-_30556088 | 1.08 |
ENST00000433809.1
|
GNL1
|
G protein nucleolar 1 (putative) |
| chr19_+_38304105 | 1.08 |
ENST00000588605.5
ENST00000301246.10 |
C19orf33
|
chromosome 19 open reading frame 33 |
| chr11_+_65182413 | 1.08 |
ENST00000531068.5
ENST00000527699.5 ENST00000533909.5 ENST00000527323.5 |
CAPN1
|
calpain 1 |
| chr16_+_89560653 | 1.07 |
ENST00000563270.5
ENST00000567815.5 ENST00000311528.10 ENST00000452368.7 ENST00000467736.5 ENST00000393099.3 |
RPL13
|
ribosomal protein L13 |
| chr16_+_50742059 | 1.06 |
ENST00000311559.13
ENST00000564326.5 ENST00000566206.5 ENST00000427738.8 |
CYLD
|
CYLD lysine 63 deubiquitinase |
| chrX_-_153926757 | 1.06 |
ENST00000461052.5
ENST00000422091.1 |
ARHGAP4
|
Rho GTPase activating protein 4 |
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.8 | 11.0 | GO:2000752 | regulation of phospholipid scramblase activity(GO:1900161) positive regulation of phospholipid scramblase activity(GO:1900163) regulation of glucosylceramide catabolic process(GO:2000752) positive regulation of glucosylceramide catabolic process(GO:2000753) regulation of sphingomyelin catabolic process(GO:2000754) positive regulation of sphingomyelin catabolic process(GO:2000755) |
| 2.0 | 8.0 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 1.8 | 5.4 | GO:1905154 | negative regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034125) negative regulation of eosinophil activation(GO:1902567) negative regulation of membrane invagination(GO:1905154) negative regulation of eosinophil migration(GO:2000417) |
| 1.3 | 3.9 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
| 1.1 | 3.3 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 0.9 | 3.8 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 0.9 | 2.6 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.8 | 2.5 | GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus(GO:0002876) |
| 0.8 | 9.3 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 0.8 | 2.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.8 | 2.3 | GO:0035732 | nitric oxide storage(GO:0035732) |
| 0.7 | 3.0 | GO:0046732 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.7 | 5.9 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.6 | 2.4 | GO:0052027 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.6 | 2.2 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 0.5 | 4.0 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
| 0.5 | 2.3 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.4 | 2.2 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.4 | 2.2 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 0.4 | 3.0 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 0.4 | 5.7 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.4 | 3.6 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.4 | 2.0 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) interleukin-3-mediated signaling pathway(GO:0038156) |
| 0.4 | 1.1 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
| 0.4 | 1.5 | GO:0033319 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.4 | 1.9 | GO:0010193 | response to ozone(GO:0010193) response to L-ascorbic acid(GO:0033591) |
| 0.4 | 2.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.3 | 1.7 | GO:0044209 | AMP salvage(GO:0044209) |
| 0.3 | 1.0 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) |
| 0.3 | 3.1 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.3 | 3.0 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.3 | 1.5 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.3 | 1.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.3 | 2.0 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.3 | 2.0 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.3 | 2.0 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.3 | 3.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.3 | 3.5 | GO:0021769 | orbitofrontal cortex development(GO:0021769) |
| 0.2 | 1.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.2 | 0.9 | GO:0050823 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 0.2 | 2.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.2 | 2.0 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
| 0.2 | 1.8 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.2 | 1.3 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.2 | 2.6 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.2 | 5.3 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.2 | 7.0 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.2 | 1.0 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
| 0.2 | 3.5 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.2 | 0.6 | GO:0060309 | elastin catabolic process(GO:0060309) |
| 0.2 | 4.3 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 0.2 | 1.6 | GO:0019732 | antifungal humoral response(GO:0019732) |
| 0.2 | 2.0 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.2 | 1.0 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
| 0.2 | 2.5 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.2 | 2.9 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.2 | 1.9 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.2 | 0.6 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
| 0.2 | 1.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.2 | 0.7 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 0.2 | 3.0 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.2 | 5.5 | GO:0007620 | copulation(GO:0007620) |
| 0.2 | 0.5 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.2 | 0.8 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.2 | 0.8 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 0.2 | 2.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.2 | 1.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.2 | 0.8 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
| 0.2 | 1.4 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.2 | 1.1 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.2 | 3.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.2 | 3.0 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.1 | 1.3 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 0.1 | 23.3 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.1 | 1.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
| 0.1 | 5.3 | GO:0045730 | respiratory burst(GO:0045730) |
| 0.1 | 0.4 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.1 | 0.6 | GO:1902256 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) positive regulation of vascular wound healing(GO:0035470) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
| 0.1 | 1.6 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.1 | 1.2 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.1 | 4.8 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.1 | 0.7 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.1 | 3.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.1 | 0.4 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
| 0.1 | 0.4 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
| 0.1 | 1.2 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.1 | 1.3 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.1 | 2.7 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.1 | 0.9 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
| 0.1 | 0.4 | GO:0001300 | chronological cell aging(GO:0001300) |
| 0.1 | 3.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.1 | 0.7 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.1 | 0.6 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.1 | 1.9 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 | 0.9 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.1 | 0.7 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.1 | 0.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.1 | 1.3 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 0.1 | 1.7 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.1 | 2.8 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.1 | 0.4 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
| 0.1 | 1.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.1 | 1.4 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.1 | 1.5 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.1 | 1.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 | 0.3 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.1 | 3.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.1 | 1.7 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
| 0.1 | 1.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.1 | 2.9 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.1 | 1.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.1 | 0.7 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.1 | 1.2 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.1 | 0.6 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 | 3.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 | 1.8 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.1 | 1.4 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.1 | 0.2 | GO:0042938 | positive regulation of cellular pH reduction(GO:0032849) dipeptide transport(GO:0042938) |
| 0.1 | 3.8 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 | 2.2 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
| 0.1 | 0.4 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 | 0.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 1.1 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) ERBB3 signaling pathway(GO:0038129) |
| 0.1 | 1.1 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.1 | 0.2 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) telomere maintenance via base-excision repair(GO:0097698) |
| 0.1 | 1.5 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.1 | 0.9 | GO:0007512 | adult heart development(GO:0007512) |
| 0.1 | 0.7 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.1 | 0.6 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.1 | 0.2 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.1 | 2.4 | GO:0019835 | cytolysis(GO:0019835) |
| 0.1 | 0.3 | GO:0071455 | cellular response to hyperoxia(GO:0071455) |
| 0.1 | 0.3 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.1 | 1.8 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 0.1 | 1.4 | GO:0007097 | nuclear migration(GO:0007097) |
| 0.1 | 1.3 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.1 | 5.1 | GO:0006611 | protein export from nucleus(GO:0006611) |
| 0.1 | 1.4 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
| 0.1 | 0.4 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.1 | 2.0 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.1 | 4.9 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.1 | 0.2 | GO:0072334 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.1 | 0.4 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.1 | 0.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 | 3.5 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.0 | 0.9 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.0 | 0.2 | GO:0048627 | myoblast development(GO:0048627) |
| 0.0 | 1.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.0 | 0.8 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.0 | 5.8 | GO:0031295 | T cell costimulation(GO:0031295) |
| 0.0 | 5.4 | GO:0042100 | B cell proliferation(GO:0042100) |
| 0.0 | 4.4 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.0 | 0.2 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.0 | 0.2 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.0 | 0.1 | GO:0046081 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.0 | 3.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.0 | 0.4 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.0 | 0.6 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 | 1.5 | GO:0060065 | uterus development(GO:0060065) |
| 0.0 | 0.0 | GO:0090427 | activation of meiosis(GO:0090427) |
| 0.0 | 1.0 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.0 | 1.6 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.0 | 1.2 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.0 | 0.6 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.0 | 1.2 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 | 0.7 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.0 | 0.5 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.0 | 0.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.0 | 0.4 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
| 0.0 | 1.5 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.0 | 0.5 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) lens induction in camera-type eye(GO:0060235) |
| 0.0 | 4.7 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.0 | 6.9 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.0 | 3.6 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
| 0.0 | 0.7 | GO:0002385 | mucosal immune response(GO:0002385) |
| 0.0 | 0.4 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.0 | 0.1 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.0 | 0.8 | GO:0097186 | amelogenesis(GO:0097186) |
| 0.0 | 1.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 | 0.7 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
| 0.0 | 0.2 | GO:1990834 | response to odorant(GO:1990834) |
| 0.0 | 0.2 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.0 | 0.1 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.0 | 0.7 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 0.0 | 0.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.0 | 1.4 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.0 | 0.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.0 | 0.3 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.0 | 0.3 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.0 | 1.9 | GO:0002292 | T cell differentiation involved in immune response(GO:0002292) |
| 0.0 | 0.2 | GO:0046070 | dGTP metabolic process(GO:0046070) |
| 0.0 | 1.1 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.0 | 6.1 | GO:0008360 | regulation of cell shape(GO:0008360) |
| 0.0 | 0.5 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.0 | 0.3 | GO:0030913 | paranodal junction assembly(GO:0030913) |
| 0.0 | 1.4 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.0 | 0.7 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.0 | 0.6 | GO:0097435 | fibril organization(GO:0097435) |
| 0.0 | 0.6 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 | 0.5 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
| 0.0 | 3.5 | GO:0002576 | platelet degranulation(GO:0002576) |
| 0.0 | 0.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.0 | 1.4 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 | 0.5 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
| 0.0 | 0.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.0 | 1.7 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.0 | 0.3 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.0 | 0.5 | GO:0022038 | corpus callosum development(GO:0022038) |
| 0.0 | 0.3 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
| 0.0 | 0.2 | GO:0048664 | neuron fate determination(GO:0048664) |
| 0.0 | 0.2 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
| 0.0 | 1.7 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.0 | 2.1 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
| 0.0 | 0.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 | 1.4 | GO:0009791 | post-embryonic development(GO:0009791) |
| 0.0 | 0.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.0 | 0.9 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
| 0.0 | 0.1 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 0.0 | 0.2 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.0 | 0.1 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.0 | 0.1 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.2 | 6.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.9 | 3.6 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.7 | 2.0 | GO:0030526 | granulocyte macrophage colony-stimulating factor receptor complex(GO:0030526) |
| 0.6 | 2.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.6 | 1.8 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.6 | 2.2 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.5 | 5.3 | GO:0032010 | phagolysosome(GO:0032010) |
| 0.5 | 1.4 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.4 | 2.6 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.4 | 4.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.4 | 2.1 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.3 | 3.0 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.3 | 2.3 | GO:0031523 | Myb complex(GO:0031523) |
| 0.3 | 6.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.3 | 2.5 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.3 | 3.0 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
| 0.3 | 1.5 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
| 0.3 | 3.1 | GO:0042611 | MHC protein complex(GO:0042611) MHC class I protein complex(GO:0042612) |
| 0.3 | 1.6 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
| 0.2 | 0.7 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.2 | 0.9 | GO:1990879 | CST complex(GO:1990879) |
| 0.2 | 4.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.2 | 3.9 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.2 | 4.9 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.2 | 2.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.1 | 5.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.1 | 1.1 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.1 | 1.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.1 | 0.9 | GO:0042825 | TAP complex(GO:0042825) |
| 0.1 | 0.8 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.1 | 0.4 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 0.1 | 1.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.1 | 0.4 | GO:0043293 | apoptosome(GO:0043293) |
| 0.1 | 2.8 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.1 | 0.6 | GO:0032044 | DSIF complex(GO:0032044) |
| 0.1 | 10.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.1 | 1.3 | GO:0030057 | desmosome(GO:0030057) |
| 0.1 | 3.2 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 2.6 | GO:0000786 | nucleosome(GO:0000786) |
| 0.1 | 1.0 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.1 | 3.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.1 | 5.9 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.1 | 4.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.1 | 1.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.1 | 1.0 | GO:0001940 | male pronucleus(GO:0001940) |
| 0.1 | 1.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.1 | 12.5 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.1 | 1.4 | GO:0042555 | MCM complex(GO:0042555) |
| 0.1 | 5.4 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.1 | 9.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.1 | 6.2 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.1 | 1.4 | GO:0032059 | bleb(GO:0032059) |
| 0.1 | 2.2 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.1 | 5.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.1 | 7.1 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.1 | 15.9 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.1 | 1.5 | GO:0010369 | chromocenter(GO:0010369) |
| 0.1 | 1.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.1 | 0.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.1 | 0.8 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.1 | 0.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.1 | 1.1 | GO:0042627 | chylomicron(GO:0042627) |
| 0.0 | 0.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.0 | 0.4 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.0 | 0.7 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.0 | 0.4 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.0 | 3.6 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.0 | 0.7 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
| 0.0 | 0.6 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
| 0.0 | 0.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.0 | 1.7 | GO:0034774 | secretory granule lumen(GO:0034774) |
| 0.0 | 2.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.0 | 1.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.0 | 2.6 | GO:0045095 | keratin filament(GO:0045095) |
| 0.0 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.0 | 2.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.0 | 0.1 | GO:0034657 | GID complex(GO:0034657) |
| 0.0 | 1.6 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
| 0.0 | 0.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.0 | 3.4 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.0 | 8.2 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
| 0.0 | 3.3 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.0 | 0.3 | GO:0044815 | DNA packaging complex(GO:0044815) |
| 0.0 | 3.2 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 0.0 | 0.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.0 | 0.2 | GO:0060091 | kinocilium(GO:0060091) |
| 0.0 | 1.2 | GO:0043034 | costamere(GO:0043034) |
| 0.0 | 2.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.0 | 6.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.0 | 0.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.0 | 0.5 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.0 | 0.3 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 0.0 | 0.6 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.0 | 0.3 | GO:0097451 | glial limiting end-foot(GO:0097451) |
| 0.0 | 2.2 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.0 | 0.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.0 | 0.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.0 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.0 | 19.7 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 1.3 | GO:0035579 | specific granule membrane(GO:0035579) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.6 | 8.0 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 1.2 | 11.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.9 | 7.7 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.8 | 4.0 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 0.8 | 2.3 | GO:0035731 | S-nitrosoglutathione binding(GO:0035730) dinitrosyl-iron complex binding(GO:0035731) |
| 0.7 | 2.0 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
| 0.6 | 4.2 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 0.6 | 3.3 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.6 | 2.2 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 0.5 | 2.5 | GO:0050473 | prostaglandin-endoperoxide synthase activity(GO:0004666) arachidonate 15-lipoxygenase activity(GO:0050473) |
| 0.5 | 3.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.4 | 2.2 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.4 | 5.7 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.4 | 7.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.4 | 2.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.4 | 1.7 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.4 | 2.0 | GO:0004914 | interleukin-3 receptor activity(GO:0004912) interleukin-5 receptor activity(GO:0004914) |
| 0.4 | 3.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.4 | 2.8 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.4 | 2.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.4 | 6.5 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 0.4 | 5.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.4 | 1.5 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
| 0.4 | 2.6 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
| 0.4 | 1.4 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
| 0.4 | 1.1 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
| 0.3 | 2.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.3 | 5.8 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
| 0.3 | 1.9 | GO:0004096 | catalase activity(GO:0004096) |
| 0.3 | 2.6 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
| 0.3 | 1.4 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.3 | 5.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.3 | 2.0 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.3 | 3.0 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 0.3 | 3.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.2 | 1.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.2 | 4.8 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.2 | 3.0 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.2 | 0.7 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.2 | 3.5 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.2 | 3.8 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.2 | 1.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.2 | 5.6 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.2 | 0.9 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) |
| 0.2 | 2.2 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.2 | 3.4 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.2 | 5.9 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.1 | 1.8 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.1 | 0.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 0.1 | 1.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 0.1 | 0.4 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
| 0.1 | 31.0 | GO:0003823 | antigen binding(GO:0003823) |
| 0.1 | 0.5 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.1 | 1.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 0.9 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.1 | 1.1 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.1 | 5.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.1 | 0.7 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.1 | 2.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.1 | 1.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.1 | 1.0 | GO:0089720 | caspase binding(GO:0089720) |
| 0.1 | 5.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.1 | 1.7 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
| 0.1 | 0.3 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
| 0.1 | 0.3 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.1 | 1.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.1 | 0.5 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 0.1 | 1.3 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.1 | 1.1 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.1 | 1.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.1 | 0.4 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.1 | 1.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.1 | 0.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.1 | 2.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.1 | 1.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.1 | 0.5 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.1 | 3.7 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.1 | 2.6 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.1 | 0.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.1 | 1.9 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.1 | 1.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.1 | 1.2 | GO:0034485 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) |
| 0.1 | 3.6 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.1 | 3.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.1 | 3.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.1 | 0.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.1 | 0.5 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.1 | 0.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 0.1 | 0.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.1 | 1.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
| 0.1 | 0.2 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
| 0.0 | 0.4 | GO:0070728 | leucine binding(GO:0070728) |
| 0.0 | 2.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.0 | 0.9 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.0 | 0.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.0 | 0.9 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
| 0.0 | 8.9 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
| 0.0 | 0.2 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
| 0.0 | 0.1 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 0.0 | 0.3 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.0 | 1.9 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.0 | 10.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.0 | 4.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.0 | 1.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.0 | 1.3 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.0 | 0.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.0 | 0.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.0 | 1.7 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.0 | 0.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.0 | 0.7 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
| 0.0 | 0.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.0 | 1.0 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.0 | 0.2 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
| 0.0 | 0.3 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.0 | 2.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.0 | 0.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.0 | 0.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.0 | 0.4 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.0 | 0.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.0 | 1.5 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.0 | 0.4 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.0 | 0.3 | GO:0031386 | protein tag(GO:0031386) |
| 0.0 | 1.4 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.0 | 1.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.0 | 2.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.0 | 1.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.0 | 2.0 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.0 | 0.1 | GO:0047315 | kynurenine-glyoxylate transaminase activity(GO:0047315) |
| 0.0 | 0.3 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.0 | 1.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.0 | 1.0 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.0 | 1.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.0 | 0.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.0 | 1.7 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.0 | 5.1 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
| 0.0 | 0.2 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.0 | 0.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
| 0.0 | 0.5 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.0 | 0.7 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.0 | 0.8 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.0 | 2.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.0 | 1.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.0 | 1.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.0 | 0.2 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
| 0.0 | 1.9 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
| 0.0 | 0.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.0 | 0.2 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
| 0.0 | 0.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.0 | 0.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.0 | 1.8 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.0 | 0.3 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.0 | 3.6 | GO:0001047 | core promoter binding(GO:0001047) |
| 0.0 | 0.3 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.0 | 1.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.0 | 0.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.0 | 0.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.0 | 0.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.0 | 0.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.0 | 0.9 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.0 | 0.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.0 | 1.2 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
| 0.0 | 1.4 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
| 0.0 | 0.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.3 | 7.9 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.3 | 18.7 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.3 | 20.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.2 | 2.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.2 | 5.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.2 | 7.6 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.1 | 1.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.1 | 2.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.1 | 9.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 2.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.1 | 10.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.1 | 1.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.1 | 6.7 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.1 | 1.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.1 | 6.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.1 | 3.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.1 | 5.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.1 | 1.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.1 | 9.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.1 | 2.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.1 | 7.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.1 | 2.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.1 | 3.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.1 | 2.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.1 | 1.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.1 | 5.0 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.1 | 1.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.1 | 3.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.1 | 0.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.1 | 2.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.0 | 2.1 | PID FOXO PATHWAY | FoxO family signaling |
| 0.0 | 2.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.0 | 0.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.0 | 0.8 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.0 | 2.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.0 | 1.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.0 | 0.7 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.0 | 0.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.0 | 1.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.0 | 0.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.0 | 1.7 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.0 | 0.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.0 | 2.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 0.9 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.0 | 1.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.0 | 0.4 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.0 | 0.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.0 | 0.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.0 | 0.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.0 | 0.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.0 | 0.8 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.0 | 0.7 | PID AURORA B PATHWAY | Aurora B signaling |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.4 | 2.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.3 | 6.5 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.3 | 3.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.2 | 2.0 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 0.2 | 11.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.2 | 15.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.2 | 9.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.2 | 6.6 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 0.2 | 5.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.2 | 5.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.2 | 4.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.1 | 8.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.1 | 5.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.1 | 6.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.1 | 4.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.1 | 5.5 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
| 0.1 | 1.2 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
| 0.1 | 6.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.1 | 3.5 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
| 0.1 | 2.6 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.1 | 3.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.1 | 1.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.1 | 1.8 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
| 0.1 | 1.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.1 | 3.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.1 | 2.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.1 | 1.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.1 | 3.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.1 | 3.8 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.1 | 4.7 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 0.1 | 1.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.1 | 3.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.1 | 1.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.1 | 5.7 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.1 | 3.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.1 | 2.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.1 | 1.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.1 | 0.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.1 | 1.9 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 0.1 | 1.1 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.0 | 2.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.0 | 0.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.0 | 1.1 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.0 | 1.0 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.0 | 1.6 | REACTOME DEFENSINS | Genes involved in Defensins |
| 0.0 | 1.2 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.0 | 1.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.0 | 0.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.0 | 4.0 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.0 | 0.2 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.0 | 0.7 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.0 | 1.0 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.0 | 0.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.0 | 0.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.0 | 2.7 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.0 | 1.7 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.0 | 2.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.0 | 0.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.0 | 2.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.0 | 0.3 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.0 | 0.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.0 | 0.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.0 | 0.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.0 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.0 | 2.2 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.0 | 0.6 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
| 0.0 | 0.5 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
| 0.0 | 0.5 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 0.0 | 1.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 0.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.0 | 0.6 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.0 | 0.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.0 | 0.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |